Share-based Payment Arrangement, Expense in USD of Inhibrx Biosciences, Inc. for Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Inhibrx Biosciences, Inc. quarterly Share-based Payment Arrangement, Expense history and change rate for Q2 2024.
Inhibrx Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 May 2024 was $1.8M.

Share-based Payment Arrangement, Expense, Quarterly (USD)

Inhibrx Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$1.8M			30 May 2024	10-K	17 Mar 2025

* An asterisk sign (*) next to the value indicates that the value is likely invalid.